Holen Sie sich die Stockscreener-App
235.12
3.76%
8.51
Handel nachbörslich:
235.12
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$226.61
Offen:
$235.545
24-Stunden-Volumen:
9.54M
Relative Volume:
0.81
Marktkapitalisierung:
$293.61B
Einnahmen:
$20.56B
Nettoeinkommen (Verlust:
$6.21B
KGV:
48.19
EPS:
4.8791
Netto-Cashflow:
$6.22B
1W Leistung:
+12.08%
1M Leistung:
+7.68%
6M Leistung:
+130.51%
1J Leistung:
+182.39%
1-Tages-Spanne:
$230.04
$240.34
1-Wochen-Bereich:
$204.57
$240.34
52-Wochen-Spanne:
$56.32
$251.87
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
235.12 | 282.98B | 20.56B | 6.21B | 6.22B | 4.8791 |
|
ASML
Asml Holding Nv
|
1,435.63 | 548.69B | 36.97B | 10.86B | 12.49B | 27.95 |
|
AMAT
Applied Materials Inc
|
339.88 | 261.19B | 28.37B | 7.00B | 5.70B | 8.6741 |
|
KLAC
Kla Corp
|
1,479.50 | 187.55B | 12.74B | 4.56B | 4.38B | 34.42 |
|
TER
Teradyne Inc
|
321.45 | 47.75B | 3.19B | 554.05M | 450.41M | 3.4814 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-29 | Hochstufung | Summit Insights | Hold → Buy |
| 2026-01-29 | Bestätigt | TD Cowen | Buy |
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Rhumbline Advisers Reduces Stock Position in Lam Research Corporation $LRCX - MarketBeat
Krilogy Financial LLC Has $3.69 Million Holdings in Lam Research Corporation $LRCX - MarketBeat
Stratos Wealth Partners LTD. Acquires 10,280 Shares of Lam Research Corporation $LRCX - MarketBeat
Wealthfront Advisers LLC Buys 8,096 Shares of Lam Research Corporation $LRCX - MarketBeat
RFG Advisory LLC Raises Stock Position in Lam Research Corporation $LRCX - MarketBeat
53,117 Shares in Lam Research Corporation $LRCX Purchased by Caprock Group LLC - MarketBeat
Lam Research Corporation $LRCX Shares Purchased by Advisors Asset Management Inc. - MarketBeat
Cadence’s Anirudh Devgan Appointed to Lam Research BOD - EE Times India
Lam Research (NASDAQ:LRCX) Trading Down 1.2% Following Insider Selling - MarketBeat
Behind the Scenes of Lam Research's Latest Options Trends - Benzinga
NVTS Trades at Premium Valuation: Should You Hold or Fold the Stock? - Finviz
Lam Research Stock's High P/E: Justified Premium or Too Pricey to Buy? - The Globe and Mail
Navellier & Associates Inc. Acquires 32,350 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research (LRCX) director Brandt sells $7.8m in stock By Investing.com - Investing.com UK
Lam Research (LRCX) director Brandt sells $7.8m in stock - Investing.com India
The Truth About Lam Research Corp (LRCX): The Chip Stock Everyone’s Sleeping On - AD HOC NEWS
Lam Research Sees Unusually Large Options Volume (NASDAQ:LRCX) - MarketBeat
Lam Research (LRCX) Just Overtook the 20-Day Moving Average - Finviz
Looking Into Lam Research Corp's Recent Short Interest - Benzinga
Candriam S.C.A. Acquires 81,888 Shares of Lam Research Corporation $LRCX - MarketBeat
This Growth Stock Continues to Crush the Market - The Motley Fool
Lam Research Corporation $LRCX Shares Acquired by Smartleaf Asset Management LLC - MarketBeat
Lam Research stock price jumps 8% as chip rally returns — what to watch next week - TechStock²
Lam Research Corporation (LRCX): A Bull Case Theory - Finviz
Lam Research Corp. stock outperforms competitors on strong trading day - MSN
Canada Post Corp Registered Pension Plan Acquires 132,115 Shares of Lam Research Corporation $LRCX - MarketBeat
Greater Midwest Financial Group LLC Acquires New Shares in Lam Research Corporation $LRCX - MarketBeat
Assessing Lam Research (LRCX) Valuation After A Strong Year Of Share Price Momentum - Yahoo Finance
Lam Research (NASDAQ:LRCX) Shares Up 8.3% Following Dividend Announcement - MarketBeat
Lam Research stock price jumps 7% as chip rebound returns — what investors watch next - TechStock²
Lam Research: The Future Is Already Here (NASDAQ:LRCX) - Seeking Alpha
May 15th Options Now Available For Lam Research (LRCX) - Nasdaq
Lam Research Corporation (NASDAQ:LRCX) Plans $0.26 Quarterly Dividend - MarketBeat
Lam Research (LRCX) is the future, says Jim Cramer - MSN
Lam Research (LRCX) Is the Future, Says Jim Cramer - Insider Monkey
Lam Research and CEA-Leti Sign Multi-Year Deal to Advance Specialty Semiconductor Technologies - EE Times India
Analysis Recap: Is Lam Research Corporation stock a hidden gemPortfolio Value Report & Short-Term High Return Ideas - baoquankhu1.vn
Lam Research stock climbs after $0.26 dividend; LRCX traders size up COO change - TechStock²
Lam Research (NASDAQ:LRCX) Stock Price Up 1.7%Here's Why - MarketBeat
Lam Research names new COO as part of leadership restructuring By Investing.com - Investing.com Nigeria
Lam Research Corporation Declares Quarterly Dividend - Chartmill
Lam Research Corp (LRCX) Stock Price Down 8.83% on Feb 5 - GuruFocus
Why Lam Research (LRCX) stock is bouncing after a bruising 9% drop - TechStock²
Wall Street Analysts Believe Lam Research (LRCX) Could Rally 30.51%: Here's is How to Trade - Finviz
Homestead Advisers Corp Trims Stake in Lam Research Corporation $LRCX - MarketBeat
Jones Financial Companies Lllp Acquires 27,223 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research (NASDAQ:LRCX) Stock Price Down 8.8%Should You Sell? - MarketBeat
Lam Research Corp. stock outperforms competitors despite losses on the day - MSN
Amtech, Vishay Intertechnology, Lam Research, Micron, and Western Digital Stocks Trade Down, What You Need To Know - Barchart.com
Jim Cramer on Lam Research: "Put a Quarter of the Position on It If You Want to Buy Lam Research, and Then Leg In" - Finviz
Jim Cramer on Lam Research: “Put a Quarter of the Position on It If You Want to Buy Lam Research, and Then Leg In” - Insider Monkey
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):